Highlights

02-03 BioDlink Modernizes Quality Management with Successful Go-Live of Veeva QMS CI
01-08 Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership MT
01-08 Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing CI
01-07 Novo Nordisk Commits to Using Veeva Systems' CRM MT
01-05 Veeva announces share repurchase program RE
01-05 Veeva Systems Reports Share Buyback Plan MT
01-05 Veeva Systems Inc. announces an Equity Buyback for $2,000 million worth of its shares. CI
01-04 Veeva Systems Inc. authorizes a Buyback Plan. CI
12-04 UiPath Joins the Veeva AI Partner Program to Deliver Secure & Trusted Agentic Testing Capabilities for Quality Management CI
12-03 Veeva Systems Announces the Availability of Veeva Ai Agents for Vault CRM and PromoMats CI
11-24 Veeva Announces Expanded Partnership with Roche CI
11-24 Veeva Systems Expands Partnership With Roche Pharmaceuticals MT
11-21 Top Midday Stories: Lilly Becomes First Pharma Company to Hit $1 Trillion Market Cap; Enviri to Sell Clean Earth to Veolia for $3.04 Billion MT
11-21 Sector Update: Health Care Stocks Rise Pre-Bell Friday MT
11-20 Veeva Systems Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal 2026 Guidance Lifted MT
11-20 (VEEV) Veeva Systems Expects Fiscal 2026 Non-GAAP EPS of About $7.93, vs. FactSet Est of $7.81 MT
11-20 (VEEV) Veeva Systems Inc. Expects Q4 Revenue Range $807.0M - $810.0M MT
11-20 (VEEV) Veeva Systems Expects Fiscal 2026 Revenue Range $3.166B-$3.169B, vs. FactSet Est of $3.14B MT
11-20 Earnings Flash (VEEV) Veeva Systems Inc. Reports Q3 Revenue $811.2M, vs. FactSet Est of $792.8M MT
11-20 Earnings Flash (VEEV) Veeva Systems Inc. Posts Q3 Adjusted EPS $2.04 per Share, vs. FactSet Est of $1.95 MT
11-20 Veeva Systems Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ending January 31, 2026 and Updates Earnings Guidance for the Fiscal Year Ending January 31, 2026 CI
11-20 Veeva Systems Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2025 CI
16/10/25 Openevidence and Veeva announce Open Vista partnership RE
03/10/25 Veeva Systems Insider Sold Shares Worth $4,378,500, According to a Recent SEC Filing MT
22/09/25 Veeva Systems says Bristol Myers Squibb commits to Veeva Vault CRM RE
No results for this search